ARTG Entry
ELOCON
ARTG entry for ELOCON (mometasone furoate), ARTG 212416 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Organon Pharma
- Active ingredient: mometasone furoate
- Therapeutic area: Dermatology
I appreciate your detailed instructions, but
I need to flag a significant issue with this request.
The source documents provided are about **NASONEX** (mometasone furoate nasal spray), not **ELOCON**. The ARTG entries reference only shows that ELOCON is a dermatological product (ointment, lotion, cream formulations), but provides no clinical, safety, dosing, or regulatory detail about ELOCON itself.
The comprehensive product information in Document 1 covers NASONEX's indications (allergic rhinitis, nasal polyps, acute rhinosinusitis), dosing, safety warnings, contraindications, and regulatory history—none of which apply to ELOCON topical dermatological products.
To produce an accurate and properly cited Brand Dossier for ELOCON, I would need: — ELOCON product information or SPC (Summary of Product Characteristics) — ELOCON PBS listing details — ELOCON regulatory history and PBAC decisions — ELOCON safety and dosing information specific to its dermatological indications
**I cannot ethically write a dossier for ELOCON using NASONEX source material**, as every claim would be false and dangerously misleading for a healthcare audience.
Please provide the correct source documents for ELOCON (the topical dermatological product), and I will produce the Brand Dossier as specified.